Drug Profile
AG SFT103
Alternative Names: AG-SFT103Latest Information Update: 20 Sep 2016
Price :
$50
*
At a glance
- Originator Ahn-Gook Pharmaceutical
- Class Antihypertensives
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 01 Sep 2016 Discontinued for Hypertension in South Korea (unspecified route)
- 23 May 2016 Early research in Hypertension in South Korea (unspecified route)